Lymphoma, Malignant Clinical Trial
Official title:
Evaluation of the Efficacy of Management of Patients With Lymphomas Diagnosed at Nimes University Hospital Over 20 Years (1999-2018) Under Real-life Circumstances
Observation of a cohort of 400 patients with different types of lymphomas.
A database on 400 patients diagnosed with lymphomas was built up over 20 years at Nîmes University Hospital. Biopsies were made on these tumours and all the samples were frozen. Considering the heterogeneous nature of lymphomas, randomized clinical trials based on very precise criteria for the inclusion or non-inclusion of patients are the gold standard for studying the various sub-types of lymphomas by concentrating on homogeneous populations for which a limited number of parameters are analyzed simultaneously. However, due to the complexity of their medical situation, many patients may be excluded form these trials, thus making it difficult to obtain reliable results. The analysis of a non-selected cohort has two main advantages: (1) to better understand the diversity of patients with lymphomas for which the recommendations are constantly evolving and (2) to analyze how, exactly, these are managed by integrating points which are currently poorly evaluated such as comorbidities and accessibility to treatment. The aim of the study is to describe how these patients are managed and to demonstrate that not all patients are able to benefit from the official management recommendations applicable to their pathology. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02916979 -
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG
|
Phase 1 | |
| Completed |
NCT00600353 -
Multi-day Doses in Prevention of Nausea and Emesis
|
Phase 2 | |
| Completed |
NCT01432951 -
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
|
Phase 1 | |
| Terminated |
NCT02440685 -
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT02249429 -
Open-Label, Non Randomized Phase 2 Study With Safety Run-In
|
Phase 2 | |
| Active, not recruiting |
NCT02732275 -
DS-3201b in Participants With Lymphomas
|
Phase 1 | |
| Completed |
NCT00509184 -
Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma
|
Phase 2 | |
| Recruiting |
NCT00619879 -
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
|
Phase 3 | |
| Completed |
NCT00146055 -
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
|
Phase 2 | |
| Completed |
NCT00741871 -
A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
|
Phase 1 | |
| Recruiting |
NCT02441972 -
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
|
Phase 1 | |
| Completed |
NCT00078637 -
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
|
Phase 1 | |
| Withdrawn |
NCT03359733 -
A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor
|
Phase 1 | |
| Completed |
NCT00037791 -
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
|
Phase 3 | |
| Completed |
NCT01388335 -
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
|
Phase 1 |